Patents Assigned to Research Development
  • Patent number: 8912788
    Abstract: System and methods for detecting substances such as explosives via the nuclear quadrupole resonance effect. We observe that the nuclear quadrupole resonances of explosives located within a cavity portal involve continuous Rabi transitions which are nonlinear processes since stimulated emission occurs. In other words, where there are no resonances caused by the presence of an explosive, high average power and low average power measurements should be identical. However, when resonances are stimulated by the system, the difference between these two conditions can be compared to determine a correction to measurements made when a person located in the cavity has explosive material on their person, without the need for separate empty portal or elaborate calibration procedures.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: December 16, 2014
    Assignee: AMI Research & Development, LLC
    Inventors: John T. Apostolos, Judy Feng, William Mouyos, Benjamin McMahon
  • Patent number: 8911713
    Abstract: Methods, compositions and products for preventing skin tumor formation or inhibiting development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an ?2 adrenergic receptor agonist, such brimonidine.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: December 16, 2014
    Assignee: Galderma Research & Development
    Inventors: Guy Bouvier, Matthew James Leoni, Michael Graeber
  • Patent number: 8911958
    Abstract: The present invention relates to the analysis of modified LDL in the context of immune complexes. In particular, ox-LDL and AGE-LDL are shown to predict the development of coronary artery disease and other micro- and macrovascular disorders, particularly in the context of diabetes.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: December 16, 2014
    Assignees: MUSC Foundation for Research Development, Department of Veterans Affairs
    Inventors: Maria F. Lopes-Virella, Gabriel T. Virella
  • Patent number: 8911751
    Abstract: The present invention concerns a method of administering at least one active pharmaceutical agent to a patient in need thereof, which method comprises the intranasal administration of a composition comprising a therapeutically effective amount of this agent, phospholipids, one or more C2-C4 alcohols and water, wherein the concentrations of the phospholipids and the one or more alcohols in the composition are in the ranges of 0.2 to 10% and 12 to 30% by weight, respectively, with the water content of said composition being not less than 30% by weight, the phospholipids forming vesicles in said composition. Further are disclosed pharmaceutical compositions and combinations suitable for intranasal delivery.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: December 16, 2014
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Elka Touitou, Biana Godin, Shaher Duchi
  • Patent number: 8911733
    Abstract: Disclosed is the use of agents and compositions that selectively inhibit the alternative complement pathway for the inhibiting or treating physiological damage resulting from traumatic brain injury (TBI), spinal cord injury (SCI), or related conditions. Preferred reagents for use in inhibition of damage resulting from TBI or SCI include those that inhibit factor B, with anti-factor B antibodies representing a particularly preferred agent.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: December 16, 2014
    Assignees: MUSC Foundation for Research Development, The Regents of the University of Colorado, a body corporate
    Inventors: Vernon Michael Holers, Joshua M. Thurman, Stephen Tomlinson, Philip F. Stahel
  • Patent number: 8912943
    Abstract: Detection of objects such as a buried explosive device while operating from a moving platform using a radio frequency emission system having two modes. An electromagnetic wave emission and detection system operates in a first mode to locate objects of interest and in a second mode to determine if an object contains explosive materials. In the first mode, the emission and detection system preferably operates as a subwavelength focusing, wideband, superlens using a near field super gain synthetic aperture continuous wave (CW) swept radar. In the second mode the system preferably enabled after detection of an object in the first mode, uses chemical detection methods such as Nuclear Quadrupole Resonance (NQR).
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: December 16, 2014
    Assignee: AMI Research & Development, LLC
    Inventors: John T. Apostolos, Judy Feng, William Mouyos
  • Patent number: 8913074
    Abstract: A method for colorization of images is presented. The method comprises the following steps: Displaying an image (102); applying multiple color markings (at least two colors are different) to the displayed image (104); automatically coloring the image by applying a constrained optimization to a cost function that is responsive to the marked colors and the intensity differences of the neighborhoods of some of all of the pixels (106); the resultant image is subsequently stored (110), displayed (108), or transferred (112).
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: December 16, 2014
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Anat Levin, Dani Lischinski, Yair Weiss
  • Patent number: 8911996
    Abstract: A porous scaffold is disclosed, the porous scaffold comprising electrospun polymeric nanofibers, wherein an average diameter of a pore of the porous scaffold is about 300 ?m is disclosed. An average diameter of the polymeric nanofibers ranges from about 100 to 400 nm. The scaffold may comprise a plurality of particles, the particles being greater than about 1 ?m in diameter. Methods of fabricating scaffolds, methods for generating tissue and methods of using scaffolds for tissue reconstruction are also disclosed.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: December 16, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Samer Srouji, Eyal Zussman, Erella Livne
  • Patent number: 8909648
    Abstract: A method of evaluating a semantic relatedness of terms. The method comprises providing a plurality of text segments, calculating, using a processor, a plurality of weights each for another of the plurality of text segments, calculating a prevalence of a co-appearance of each of a plurality of pairs of terms in the plurality of text segments, and evaluating a semantic relatedness between members of each the pair according to a combination of a respective the prevalence and a weight of each of the plurality of text segments wherein a co-appearance of the pair occurs.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: December 9, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Ran El-Yaniv, David Yanay
  • Patent number: 8906177
    Abstract: A method for controlling a contact angle between a glue and a surface of a substrate during manufacture of microchip packages is disclosed. The method includes applying a glue to a surface of a substrate, and placing an electrode in electrical connection with the glue. A potential difference is applied between the electrode and the substrate. The potential difference is applied across the glue and causes a contact angle between the glue and the surface of the substrate to be altered.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: December 9, 2014
    Assignee: STMicroelectronics (Research & Development) Limited
    Inventor: William Halliday
  • Patent number: 8906882
    Abstract: Provided herein are methods of treating, suppressing, inhibiting, or preventing allergic rhinitis in a subject comprising the step of administering to a subject a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: December 9, 2014
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem
    Inventor: Saul Yedgar
  • Patent number: 8901357
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, compounds having the general formula (I): are described. A process for preparing such compounds and their cosmetic or dermatological use are also described. The described compounds can act as bactericides. As a result, they can be useful in the treatment of conditions associated with the presence of bacteria, more specifically of P. acnes.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: December 2, 2014
    Assignee: Galderma Research & Development
    Inventors: Nicolas Rodeville, Jean-Claude Pascal, Claire Bouix-Peter
  • Patent number: 8902966
    Abstract: A video decoding circuit comprising: a first video data processor; a second video data processor; and a connection connecting the first video data processor and the second data processor; wherein the first video data processor is arranged to receive a first signal comprising encoded video data, process the first signal to provide a second signal and output the second signal. The first video data processor being arranged to process the first signal dependent on at least part of the received first signal. The second video data processor is arranged to receive at least a part of the second signal, process the at least a part of the second signal to provide a third signal, and output the third signal, the second and third signals comprising a decoded video image stream. The second video data processor is arranged to process the at least part of the second signal dependent on at least part of the at least part of second signal.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: December 2, 2014
    Assignees: STMicroelectronics (Research & Development) Limited, STMicroelectronics S.R.L.
    Inventors: Martin Bolton, Michele Carrano
  • Patent number: 8901926
    Abstract: Nuclear quadrupole resonance measurement using two or more wire loop(s) within a space to define a portal, and driving the wire loop(s) with a baseband digital transmitter generating a chirped or stepped signal, to create a corresponding varying electromagnetic field within the portal. Coherent emissions reflected thereby are detected through a directional coupler feeding the transceiver. The detected coherent emissions are processed with a matched filter to determine presence of a target object within the portal.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: December 2, 2014
    Assignee: AMI Research & Development, LLC
    Inventors: John T. Apostolos, Judy Feng, William Mouyos, Benjamin McMahon
  • Patent number: 8900858
    Abstract: The present invention provides HIV-derived lentivectors which are multiply modified to create highly safe, efficient, and potent vectors for expressing transgenes for gene therapy. The lentiviral vectors comprise various combinations of an inactive central polypurine tract, a stuffer sequence, which may encode drug susceptibility genes, and a mutated hairpin in the 5? leader sequence that substantially abolishes replication. These elements are provided in conjunction with other features of lentiviral vectors, such as a self-inactivating configuration for biosaftey and promoters such as the EF1? promoter as one example. Additional promoters are also described. The vectors can also comprise additional transcription enhancing elements such as the wood chuck hepatitis virus post-transcriptional regulatory element.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: December 2, 2014
    Assignee: Research Development Foundation
    Inventors: Didier Trono, Romain N. Zufferey
  • Patent number: 8901103
    Abstract: This invention provides a method of treating a subject suffering from a dermatologic condition, including, inter alia, psoriasis, contact dermatitis, and seboreic dermatitis, the method includes the step of administering to a subject a compound comprising a lipid or phospholipid moiety bound to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof, in an amount effective to treat the subject suffering from a dermatologic condition.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: December 2, 2014
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventor: Saul Yedgar
  • Patent number: 8894227
    Abstract: A method and apparatus for correcting optical aberrations in an optical device using a deformable mirror. An actuator is provided which applies a deforming force to the deformable mirror. By selecting particular thickness profiles of the deformable mirror and force configurations of the actuator, the optical device can be configured to correct for different optical aberrations. The actuator may be configured to apply the deforming force peripherally, centrally, non-centrally or homogenously across the surface of the deformable mirror. The deformable mirror may be a flat disk mirror, a convex mirror, or a concave mirror, and may include a membrane having a variable flexibility. The optical device may be a wide-field microscope, an optical read/write device, laser tweezers, or any other optical device in which correction of optical aberrations is desirable.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: November 25, 2014
    Assignees: The Regents of the University of California, Yeda Research & Development Co. Ltd.
    Inventors: Peter Knor, David A. Agard, Zvi Kam, John W. Sedat
  • Patent number: 8895054
    Abstract: The present invention concerns methods of joint lubrication and/or prevention of cartilage wear making use of liposomes having membranes with at least one phospholipid (PL) of the group consisting of a glycerophospholipid (GPL) having two, being the same or different, C12-C16 hydrocarbon chain and a sphingolipid (SPL) having a C12-C15 hydrocarbon chain, the one or more membranes having a phase transition temperature in which solid ordered (SO) to liquid disordered (LD) phase transition occurs, the phase transition temperature being within a temperature of about 20° C. to about 39° C. for lubrication of joints.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: November 25, 2014
    Assignees: Technion Research and Development Foundation Ltd., Hadasit Medical Research Services & Development Limited, Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Yechezkel Barenholz, Dorit Nitzan, Izhak Etsion, Avi Schroeder, Grigory Halperin, Sarit Sivan
  • Patent number: 8895519
    Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: November 25, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Timor Baasov, Dana Atia-Glikin, Jeyakumar Kandasamy, Valery Belakhov
  • Patent number: 8889148
    Abstract: Methods and compositions concerning mutant flaviviruses with host-range phenotypes are provided. Nucleotide sequences that encode mutant flavivirus proteins are also provided. In certain aspects, viruses comprising these sequences display reduced replication in mammalian cells. In further aspects of the invention, flavivirus vaccine compositions and methods for vaccination against flavivirus infection are provided.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: November 18, 2014
    Assignee: Research Development Foundation
    Inventors: Dennis T. Brown, Raquel Hernandez